Exploring the Cause of the Most Ancient Clinical Sign of Medicine: Finger Clubbing

Seminars in Arthritis and Rheumatism

Volumn 36, Issue 6, 2007, Pages 380-385

  Martinez Lavin, Manuel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

cancer; cyanotic heart disease; digital clubbing; history of medicine; hypertrophic osteoarthropathy; megakaryocytes; POEMS syndrome; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTICLE; CELL ACTIVATION; CLINICAL FEATURE; CLUBBING FINGERS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; MEDICAL RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC; RHEUMATOLOGY; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 34248658800     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.11.004     Document Type: Article

References (46)

1. Lyons A.S., and Petrucelli R.J. Medicine: An Illustrated History (1978), Abrams INC Publishers, New York 216
2. Bamberger E. Uber knochenveränderugen bei chronishen lungen und herzkrankheiten. Z Klin Med 18 (1891) 193-217
3. Marie P. De l'ostéo-arthropathie hypertrophiante pneumique. Rev Med 10 (1890) 1-36
4. Martinez-Lavin M. Hypertrophic osteoarthropathy. In: Hochberg M., Silman A.J., Smolen J.S., Weinblatt M.E., and Weisman M.H. (Eds). Rheumatology. 4th Edition (2007), Mosby, Edinburgh
5. Pineda E., and Martinez-Lavin M. Hypertrophic osteoarthropathy in congenital cyanotic cardiopathy, description of 2 cases. Arch Inst Cardiol Mex 50 (1980) 151-155
6. Martínez-Lavín M., Bobadilla M., Casanova J., Attié F., and Martínez M. Hypertrophic osteoarthropathy in cyanotic congenital heart disease: its prevalence and relationship to bypass of the lung. Arthritis Rheum 25 (1982) 1186-1193
7. Flavell G. Reversal of pulmonary hypertrophic osteoarthropathy by vagotomy. Lancet 1 (1956) 260-262
8. Greco F., and Kushner I. Loss of symptoms of pulmonary hypertrophic osteoarthropathy after laparotomy. Ann Intern Med 81 (1974) 555-556
9. Martínez-Lavín M. Digital clubbing and hypertrophic ostearthropathy: a unifying hypothesis. J Rheumatol 14 (1987) 6-8
10. Dickinson C.J., and Martin J.F. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet ii (1987) 1434-1435
11. Vazquez-Abad D., and Martínez-Lavín M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 9 (1991) 59-62
12. Zucker-Franklin D., and Philipp C.S. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 157 (2000) 69-74
13. Matucci-Cerinic M., Martínez-Lavín M., Rojo F., Fonseca C., and Kahaleh B. von Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol 19 (1992) 765-767
14. Pineda C., Weisman M., Guerra A., Resnick D., and Martínez-Lavín M. The skeletal manifestations of clubbing: a study in patients with cyanotic heart disease and hypertrophic osteoarthropathy. Semin Arthritis Rheum 14 (1985) 263-267
15. Pineda C., Martínez-Lavín M., Goobar J., Sartoris D., Clopton P., and Resnick D. Periostitis in hypertrophic osteoarthropathy. AJR Am J Roentgenol 148 (1987) 773-778
16. Fonseca C., Martinez-Lavin M., Hernandez-Rodriguez N., and Osornio-Vargas A. Circulating plasma levels of platelet-derived growth factor in patients with hypertrophic osteoarthropathy. Clin Exp Rheumatol 10 Suppl. 7 (1992) 73
17. Martínez-Lavín M., Vargas A.S., Cabré J., Nava A., Silveira L.H., Amigo M.C., et al. Features of hypertrophic osteoarthropathy in patients with POEMS syndrome: a metaanalysis. J Rheumatol 24 (1997) 2267-2268
18. Watanabe O., Arimura K., Kitajima I., Osame M., Maruyama I., Authier F.J., et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347 (1996) 702
19. Soubrier M., Dubost J.J., Serre A.F., Ristori J.M., Sauvezie B., Cathebras P., et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 40 (1997) 786-787
20. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
21. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
22. Silveira L.H., Martínez-Lavín M., Pineda C., Fonseca M.C., Navarro C., and Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 18 (2000) 57-62
23. Olan F., Portela M., Navarro C., Gaxiola M., Silveira L.H., Ruiz V., et al. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity. J Rheumatol 31 (2004) 614-616
24. Atkinson S., and Fox S.B. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 203 (2004) 721-728
25. Fara E.F., and Baughman R.P. A study of capillary morphology in the digits of patients with acquired clubbing. Am Rev Respir Dis 140 (1989) 1063-1066
26. Currie A.E., and Gallagher P.J. The pathology of clubbing: vascular changes in the nail bed. Br J Dis Chest 82 (1988) 382-385
27. Schumacher Jr. H.R. Articular manifestations of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma. Arthritis Rheum 19 (1976) 629-636
28. Dixey J., Redington A.N., Butler R.C., Smith M.J., Batchelor J.R., Woodrow D.F., et al. The arthropathy of cystic fibrosis. Ann Rheum Dis 47 (1988) 218-223
29. Adekile A.D. Arterial oxygen tension, haemoglobin F and red cell 2, 3 diphosphoglycerate in sickle cell anaemia patients with digital clubbing. Ann Trop Paediatr 9 (1989) 165-168
30. Paton J.Y., Bautista D.B., Stabile M.W., Waldman A.E., Nassar A.G., Platzker A.C., et al. Digital clubbing and pulmonary function abnormalities in children with lung disease. Pediatr Pulmonol 10 (1991) 25-29
31. Coutts I.I., Gilson J.C., Kerr I.H., Parkes W.R., and Turner-Warwick M. Significance of finger clubbing in asbestosis. Thorax 42 (1987) 117-119
32. Fatourechi V., Bartley G.B., Eghbali-Fatourech G.Z., Powell C.C., Ahmed D.D., and Carrity J.A. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy. Thyroid 13 (2003) 1141-1144
33. Lemen R.J., Gates A.J., Mathe A.A., Waring W.W., Hyman A.L., and Kadowitz P.D. Relationships among digital clubbing, disease severity, and serum prostaglandins F2alpha and E concentrations in cystic fibrosis patients. Am Rev Respir Dis 117 (1978) 639-646
34. Cattral M.S., Altraif I., Greig P.D., Blendis L., and Levy G.A. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 97 (1994) 369-373
35. Hirakata Y., and Kitamura S. Elevated serum transforming growth factor beta 1 level in primary lung cancer patients with finger clubbing. Eur J Clin Invest 26 (1996) 820-823
36. Siahanidou T., Nikolaidou P., Doudounakis S., Georgouli E., Papadimitriou A., and Karpathios T. Plasma immunoreactive endothelin levels in children with cystic fibrosis. Acta Paediatr 89 (2000) 915-920
37. Yorgancioglu A., Akin M., Demtray M., and Derelt S. The relationship between digital clubbing and serum growth hormone level in patients with lung cancer. Monaldi Arch Chest Dis 5 (1996) 85-87
38. Epstein O., Ajdukiewicz A.B., Dick R., and Sherlock S. Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature. Am J Med 67 (1979) 88-97
39. Langle U.W., Bruggemann S., Prentice D.E., Ettlin R.A., Richardson B., Naef R., et al. Hypertrophic osteopathy in rats following chronic administration of SDZ MNS 949, an isoquinoline. Exp Toxicol Pathol 45 (1994) 473-479
40. Himeno W., Akagi T., Furui J., Maeno Y., Ishii M., Kosai K., et al. Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatric Cardiol 24 (2003) 127-132
41. Fehrenbach H., Kasper M., Haase M., Schuh D., and Muller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec 254 (1999) 61-73
42. Nagura S., Katoh R., Miyagi E., Shibuya M., and Kawaoi A. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possible correlates with increased vascular density. Human Pathol 32 (2001) 10-17
43. Ohta Y., Shridhar V., Bright R.K., et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81 (1999) 54-61
44. Li C.P., Lee F.Y., Hwang S.J., et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol 9 (2003) 2832-2835
45. Fontanini G., Vignati S., Boldrini L., Chine S., Silvestri V., Lucchi M., et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3 (1997) 861-865
46. Harada S., Nagy J.A., Sullivan K.A., Thomas K.A., Endo N., Rodan G.A., et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93 (1994) 2490-2496